SLC5A2 and hydrops fetalis: Compared to placebo, the ACEIs, ARNIs, and SGLT2 inhibitors significantly reduced hospitalization due to HF (HF hospitalization) [OR = 0.64 (95%CI 0.43 − 0.96), OR = 0.73 (95%CI 0.61 − 0.86), and OR = 0.74 (95%CI 0.66 − 0.83), respectively], without heterogeneity among studies.